Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Recursion Pharmaceuticals, Inc. (RXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.38-0.88 (-9.50%)
At close: 04:00PM EST
8.35 -0.03 (-0.36%)
After hours: 05:49PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/25/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
1.75B1.85B1.41B1.23B2.92B3.88B
Enterprise Value
1.35B1.39B869.48M722.70M2.35B3.26B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
55.61101.09108.8089.75287.41460.65
Price/Book (mrq)
4.514.232.852.264.876.04
Enterprise Value/Revenue
47.33106.56113.61136.38938.091.31k
Enterprise Value/EBITDA
-5.71-24.21-13.85-13.59-37.39-72.88

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-51.21%
S&P500 52-Week Change 3-13.51%
52 Week High 321.19
52 Week Low 34.92
50-Day Moving Average 310.68
200-Day Moving Average 38.91

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 31.42M
Shares Outstanding 5181.7M
Implied Shares Outstanding 6N/A
Float 8127.15M
% Held by Insiders 17.08%
% Held by Institutions 179.55%
Shares Short (Nov 14, 2022) 414.92M
Short Ratio (Nov 14, 2022) 414.16
Short % of Float (Nov 14, 2022) 411.13%
Short % of Shares Outstanding (Nov 14, 2022) 47.87%
Shares Short (prior month Oct 13, 2022) 415.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-860.27%

Management Effectiveness

Return on Assets (ttm)-24.30%
Return on Equity (ttm)-50.03%

Income Statement

Revenue (ttm)28.7M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)419.30%
Gross Profit (ttm)-125.09M
EBITDA -236.12M
Net Income Avi to Common (ttm)-246.92M
Diluted EPS (ttm)-1.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)454.65M
Total Cash Per Share (mrq)2.4
Total Debt (mrq)52.19M
Total Debt/Equity (mrq)13.45
Current Ratio (mrq)5.80
Book Value Per Share (mrq)2.23

Cash Flow Statement

Operating Cash Flow (ttm)-99.93M
Levered Free Cash Flow (ttm)-123.3M
Advertisement
Advertisement